Pethema Foundation

This study is testing a new treatment protocol for adults with a specific type of acute lymphoblastic leukemia (ALL). Researchers want to see if adding an immunotherapy drug called blinatumomab to chemotherapy leads to better survival rates than the older chemotherapy-only approa…

This large, global study is for adults newly diagnosed with acute myeloid leukemia (AML) who are too old or have other health problems that make standard intensive chemotherapy too risky. It will test if adding a drug called quizartinib to a current two-drug standard therapy help…